PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $26.15, but opened at $27.33. PureTech Health shares last traded at $27.48, with a volume of 308 shares traded.
PureTech Health Price Performance
The stock’s 50-day moving average price is $26.44 and its 200-day moving average price is $23.59.
PureTech Health Company Profile
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the Dow Jones Industrial Average (DJIA)?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is MarketRank™? How to Use it
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.